Abstract
OCT4 plays critical roles in self-renewal and pluripotency maintenance of embryonic stem cells, and is considered as one of the main stemness markers. It also has pivotal roles in early stages of embryonic development. Most studies on OCT4 have focused on the expression and function of OCT4A, which is the biggest isoform of OCT4 known so far. Recently, many studies have shown that OCT4 has various transcript variants, protein isoforms, as well as pseudogenes. Distinguishing the expression and function of these variants and isoforms is a big challenge in expression profiling studies of OCT4. Understanding how OCT4 is functioning in different contexts, depends on knowing of where and when each of OCT4 transcripts, isoforms and pseudogenes are expressed. Here, we review OCT4 known transcripts, isoforms and pseudogenes, as well as its interactions with other proteins, and emphasize the importance of discriminating each of them in order to understand the exact function of OCT4 in stem cells, normal development and development of diseases.
Graphical Abstract
Similar content being viewed by others
Data Availability
Not applicable.
Abbreviations
- Arid3a:
-
AT-rich interactive domain-containing protein 3A
- Asf1a:
-
Anti-Silencing Function 1A
- BLAST:
-
Basic local alignment search tool
- c-MYC:
-
Cellular-Myelocytomatosis
- CTD:
-
N-transactivation domain
- ChIP:
-
Chromatin Immunopercipitation
- Cdy1:
-
Chromodomain Y-Linked 1
- DNA:
-
Deoxyribonucleic acid
- Dppa5:
-
Developmental Pluripotency Associated 5
- Dnmt3b:
-
DNA-methyltransferase 3 beta
- Dax1:
-
Dosage-sensitive sex reversal
- Dpf2:
-
Double PHD Fingers 2
- ESC:
-
Embryonic stem cell
- ESRRB:
-
Estrogen Related Receptor Beta
- Fbxo15:
-
F-Box Protein 15
- HTMase:
-
Histone demethylase
- H3K9me3:
-
Histon 3 Lysine 9 three methylation
- HCC:
-
Hepatocellular carcinoma
- Hells:
-
Helicase, Lymphoid Specific
- Hdac1:
-
Histone deacetylase 1
- IRES:
-
Internal ribosome entry site
- KLF4:
-
Kruppel-like factor 4
- Lefty1:
-
Left-Right Determination Factor 1
- Lig3:
-
DNA NA Ligase 3
- LSD1:
-
Lysine-specific histone demethylase 1
- Msh2:
-
MutS homolog 2
- MTA1:
-
Metastasis-associated protein 1
- NTD:
-
N-transactivation domain
- Nac1:
-
Nucleus accumbens-associated protein 1
- NurD:
-
Ncleosome remodeling and deacetylase
- OCT4:
-
Octamer transcription factor 4
- Otx2:
-
Orthodenticle Homeobox 2
- Pit-1a:
-
Pituitary-specific positive transcription factor 1
- pg:
-
Pseudogene
- Phc1:
-
Polyhomeotic-like protein 1
- Pnkp:
-
Polynucleotide Kinase 3’-Phosphatase
- Prkdc:
-
Protein Kinase
- DNA:
-
Activated, Catalytic Subunit
- PTMs:
-
Post translational modifications
- PGCs:
-
Primordial Germ Cells
- RNA:
-
Ribonucleic acid
- RA:
-
Retinoic acid
- NT-2:
-
NTERA-2
- RT-qPCR:
-
Reverse transcription-quantitative Polymerase Chain Reaction
- RPA1:
-
Replication protein A1
- Rbbp7:
-
RB Binding Protein 7
- Rcor2:
-
REST Corepressor 2
- SOX2:
-
SRY-box transcription factor 2
- SNP:
-
Single nucleotide polymorphism
- SINE:
-
Short interespersed nuclear repetitive DNA element
- Spp1:
-
Secreted Phosphoprotein 1;
- Sall1:
-
Spalt Like Transcription Factor 1
- Sp1:
-
Specificity protein 1
- SWI/SNF:
-
SWItch/Sucrose Non-Fermentable
- Sf1:
-
Splicing factor 1
- TSS:
-
Transcription start site
- TF:
-
Transcription factor
- TE:
-
Transposable element
- Tcfcp2l1:
-
Transcription Factor CP2 Like 1
- TGF-b:
-
Transforming growth factor beta
- UCSC:
-
University of California Santa Cruz
- UTF1:
-
Undifferentiated Embryonic Cell Transcription Factor 1
- Up1:
-
Uridine Phosphorylase 1
- VSELs:
-
Very small embryonic-like stem cells
- WT1:
-
Wilm’s tumor 1
- MEF-2:
-
Myocyte enhancer factor-2
- Wnt:
-
Wingless-related integration site
- Xrcc1:
-
X-ray repair cross-complementing protein 1
- yy1:
-
Yin Yang 1
- Zfp:
-
Zinc finger protein
- Zfp15:
-
Zinc finger protein 15
References
Martin, G. R. (1981). Isolation of a Pluripotent Cell Line from Early Mouse Embryos Cultured in Medium Conditioned by Teratocarcinoma Stem Cells. Proceedings of the National Academy of Sciences, 78(12), 7634–7638.
Thomson, J. A., et al. (1998). Embryonic Stem Cell Lines Derived from Human Blastocysts. Science, 282(5391), 1145–1147.
Chambers, I., & Tomlinson, S. R. (2009). The Transcriptional Foundation of Pluripotency. Development, 136(14), 2311–2322.
Schoorlemmer, J., Jonk, L., Shen, S., van Puijenbroek, A., Feijen, A., & Kruijer, W. (1995). Regulation of Oct-4 Gene Expression During Differentiation of EC cells. Molecular Biology Reports, 21(3), 129–140.
Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., Schöler, H., & Smith, A. (1998). Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4. Cell, 95(3), 379–391.
Matin, M. M., Walsh, J. R., Gokhale, P. J., Draper, J. S., Bahrami, A. R., Morton, I., Moore, H. D., & Andrews, P. W. (2004). Specific Knockdown of Oct4 and β2-Microglobulin Expression by RNA Interference in Human Embryonic Stem Cells and Embryonic Carcinoma Cells. Stem Cells, 22(5), 659–668.
Zangrossi, S., Marabese, M., Broggini, M., Giordano, R., D'Erasmo, M., Montelatici, E., Intini, D., Neri, A., Pesce, M., Rebulla, P., & Lazzari, L. (2007). Oct-4 Expression in Adult Human Differentiated Cells Challenges its Role as a Pure Stem Cell Marker. Stem Cells, 25(7), 1675–1680.
Liedtke, S., Stephan, M., & Kögler, G. (2008). Oct4 Expression Revisited: Potential Pitfalls for Data Misinterpretation in Stem Cell Research. Biological Chemistry, 389(7), 845–850.
Trosko, J. E. (2006). From Adult Stem Cells to Cancer Stem Cells: Oct-4 Gene, Cell–Cell Communication, and Hormones During Tumor Promotion. Annals of the New York Academy of Sciences, 1089(1), 36–58.
Wang, X., & Dai, J. (2010). Concise Review: Isoforms of OCT4 Contribute to the Confusing Diversity in Stem Cell Biology. Stem Cells, 28(5), 885–893.
Liedtke, S., Enczmann, J., Waclawczyk, S., Wernet, P., & Kögler, G. (2007). Oct4 and its Pseudogenes Confuse Stem Cell Research. Cell Stem Cell, 1(4), 364–366.
Baralle, F. E., & Giudice, J. (2017). Alternative Splicing as a Regulator of Development and Tissue Identity. Nature Reviews Molecular Cell Biology, 18(7), 437–451.
Cheetham, S. W., Faulkner, G. J., & Dinger, M. E. (2020). Overcoming challenges and dogmas to understand the functions of pseudogenes. Nature Reviews Genetics, 21(3), 191–201.
Takeda, J., Seino, S., & Bell, G. I. (1992). Human Oct3 Gene Family: cDNA Sequences, Alternative Splicing, Gene Organization, Chromosomal Location, and Expression at low Levels in Adult Tissues. Nucleic Acids Research, 20(17), 4613–4620.
Hammachi, F., Morrison, G. M., Sharov, A. A., Livigni, A., Narayan, S., Papapetrou, E. P., O'Malley, J., Kaji, K., Ko, M. S. H., Ptashne, M., & Brickman, J. M. (2012). Transcriptional Activation by Oct4 is Sufficient for the Maintenance and Induction of Pluripotency. Cell Reports, 1(2), 99–109.
Atlasi, Y., Mowla, S. J., Ziaee, S. A. M., Gokhale, P. J., & Andrews, P. W. (2008). OCT4 Spliced Variants are Differentially Expressed in Human Pluripotent and Nonpluripotent Cells. Stem Cells, 26(12), 3068–3074.
Gao, Y., Wang, X., Han, J., Xiao, Z., Chen, B., Su, G., & Dai, J. (2010). The Novel OCT4 Spliced Variant OCT4B1 can Generate Three Protein Isoforms by Alternative Splicing into OCT4B. Journal of Genetics and Genomics, 37(7), 461–465.
Poursani, E. M., et al. (2017). OCT4B2, a Novel Alternative Spliced Variant of OCT4, is Significantly Upregulated Under Heat-Stress Condition and Downregulated in Differentiated Cells. Tumor Biology, 39(10), 1010428317724280.
Poursani, E. M., et al. (2017). A Novel Variant of OCT4 Entitled OCT4B3 is Expressed in Human Bladder Cancer and Astrocytoma Cell Lines. Avicenna Journal of Medical Biotechnology, 9(3), 142.
Poursani, E. M., Mehravar, M., Soltani, B. M., & Mowla, S. J. (2017). Novel Variant of OCT4B4 is Differentially Expressed in Human Embryonic Stem and Embryonic Carcinoma Cells. Gene, 627, 369–372.
Wang, X., Zhao, Y., Xiao, Z., Chen, B., Wei, Z., Wang, B., Zhang, J., Han, J., Gao, Y., Li, L., Zhao, H., Zhao, W., Lin, H., & Dai, J. (2009). Alternative Translation of OCT4 by an Internal Ribosome Entry Site and its Novel Function in Stress Response. Stem Cells, 27(6), 1265–1275.
Malakootian, M., Mirzadeh Azad, F., Naeli, P., Pakzad, M., Fouani, Y., Taheri Bajgan, E., Baharvand, H., & Mowla, S. J. (2017). Novel Spliced Variants of OCT4, OCT4C and OCT4C1, with Distinct Expression Patterns and Functions in Pluripotent and Tumor Cell Lines. European Journal of Cell Biology, 96(4), 347–355.
Zhao, F.-Q., Misra, Y., Li, D. B., Wadsworth, M. P., Krag, D., Weaver, D., Tessitore, J., Li, D. W., Zhang, G., Tian, Q., & Buss, K. (2018). Differential Expression of Oct3/4 in Human Breast Cancer and Normal Tissues. International Journal of Oncology, 52(6), 2069–2078.
Cauffman, G., Liebaers, I., van Steirteghem, A., & van de Velde, H. (2006). POU5F1 Isoforms Show Different Expression Patterns in Human Embryonic Stem Cells and Preimplantation Embryos. Stem Cells, 24(12), 2685–2691.
Herr, W., & Cleary, M. A. (1995). The POU domain: Versatility in Transcriptional Regulation by a Flexible two-in-one DNA-Binding Domain. Genes & Development, 9(14), 1679–1693.
Sturm, R. A., & Herr, W. (1988). The POU Domain is a Bipartite DNA-Binding Structure. Nature, 336(6199), 601–604.
Brehm, A., Ohbo, K., & Schöler, H. (1997). The Carboxy-Terminal Transactivation Domain of Oct-4 Acquires Cell Specificity Through the POU Domain. Molecular and Cellular Biology, 17(1), 154–162.
Poursani, E. M., Mehravar, M., Shahryari, A., Mowla, S. J., & Mohammad Soltani, B. (2017). Alternative Splicing Generates Different 5′ UTRs in OCT4B Variants. Avicenna journal of medical biotechnology, 9(4), 201–204.
Gao, J., Li, W. X., Feng, S. Q., Yuan, Y. S., Wan, D. F., Han, W., & Yu, Y. (2008). A Protein–Protein Interaction Network of Transcription Factors Acting During Liver Cell Proliferation. Genomics, 91(4), 347–355.
Rizzino, A. (2013). Concise Review: The Sox2-Oct4 Connection: Critical Players in a much Larger Interdependent Network Integrated at Multiple Levels. Stem Cells, 31(6), 1033–1039.
van den Berg, D. L., et al. (2010). An Oct4-Centered Protein Interaction Network in Embryonic Stem Cells. Cell Stem Cell, 6(4), 369–381.
Pardo, M., Lang, B., Yu, L., Prosser, H., Bradley, A., Babu, M. M., & Choudhary, J. (2010). An Expanded Oct4 Interaction Network: Implications for Stem Cell Biology, Development, and Disease. Cell Stem Cell, 6(4), 382–395.
van den Berg, D. L., et al. (2008). Estrogen-Related Receptor Beta Interacts with Oct4 to Positively Regulate Nanog Gene Expression. Molecular and Cellular Biology, 28(19), 5986–5995.
Liu, X., Huang, J., Chen, T., Wang, Y., Xin, S., Li, J., Pei, G., & Kang, J. (2008). Yamanaka Factors Critically Regulate the Developmental Signaling Network in Mouse Embryonic Stem Cells. Cell Research, 18(12), 1177–1189.
Loh, Y.-H., Wu, Q., Chew, J. L., Vega, V. B., Zhang, W., Chen, X., Bourque, G., George, J., Leong, B., Liu, J., Wong, K. Y., Sung, K. W., Lee, C. W. H., Zhao, X. D., Chiu, K. P., Lipovich, L., Kuznetsov, V. A., Robson, P., Stanton, L. W., Wei, C. L., Ruan, Y., Lim, B., & Ng, H. H. (2006). The Oct4 and Nanog Transcription Network Regulates Pluripotency in Mouse Embryonic Stem Cells. Nature Genetics, 38(4), 431–440.
Chen, X., Xu, H., Yuan, P., Fang, F., Huss, M., Vega, V. B., Wong, E., Orlov, Y. L., Zhang, W., Jiang, J., Loh, Y. H., Yeo, H. C., Yeo, Z. X., Narang, V., Govindarajan, K. R., Leong, B., Shahab, A., Ruan, Y., Bourque, G., Sung, W. K., Clarke, N. D., Wei, C. L., & Ng, H. H. (2008). Integration of External Signaling Pathways with the core Transcriptional Network in Embryonic Stem Cells. Cell, 133(6), 1106–1117.
Ivanova, N., Dobrin, R., Lu, R., Kotenko, I., Levorse, J., DeCoste, C., Schafer, X., Lun, Y., & Lemischka, I. R. (2006). Dissecting Self-Renewal in Stem Cells with RNA Interference. Nature, 442(7102), 533–538.
Zhang, X., Zhang, J., Wang, T., Esteban, M. A., & Pei, D. (2008). Esrrb Activates Oct4 Transcription and Sustains Self-Renewal and Pluripotency in Embryonic Stem Cells. Journal of Biological Chemistry, 283(51), 35825–35833.
Chen, Y. T. (2001). The metabolic and molecular bases of inherited disease. Glycogen storage diseases, 1521–1551.
Niakan, K. K., Davis, E. C., Clipsham, R. C., Jiang, M., Dehart, D. B., Sulik, K. K., & McCabe, E. R. B. (2006). Novel Role for the Orphan Nuclear Receptor Dax1 in Embryogenesis, Different from Steroidogenesis. Molecular Genetics and Metabolism, 88(3), 261–271.
Kim, J., Chu, J., Shen, X., Wang, J., & Orkin, S. H. (2008). An Extended Transcriptional Network for Pluripotency of Embryonic Stem Cells. Cell, 132(6), 1049–1061.
Malleshaiah, M., Padi, M., Rué, P., Quackenbush, J., Martinez-Arias, A., & Gunawardena, J. (2016). Nac1 Coordinates a Sub-Network of Pluripotency Factors to Regulate Embryonic Stem Cell Differentiation. Cell Reports, 14(5), 1181–1194.
Jinawath, N., Vasoontara, C., Yap, K. L., Thiaville, M. M., Nakayama, K., Wang, T. L., & Shih, I. M. (2009). NAC-1, a Potential Stem Cell Pluripotency Factor, Contributes to Paclitaxel Resistance in Ovarian Cancer Through Inactivating Gadd45 Pathway. Oncogene, 28(18), 1941–1948.
Nakayama, K., Nakayama, N., Davidson, B., Sheu, J. J. C., Jinawath, N., Santillan, A., Salani, R., Bristow, R. E., Morin, P. J., Kurman, R. J., Wang, T. L., & Shih, I. M. (2006). A BTB/POZ Protein, NAC-1, is Related to Tumor Recurrence and is Essential for Tumor Growth and Survival. Proceedings of the National Academy of Sciences, 103(49), 18739–18744.
Spengler, D., & Hoffmann, A. (2019). Chromatin Remodeling Complex NuRD in Neurodevelopment and Neurodevelopmental Disorders. Frontiers in Genetics, 10, 682.
Roberts, C. W., & Orkin, S. H. (2004). The SWI/SNF Complex—Chromatin and Cancer. Nature Reviews Cancer, 4(2), 133–142.
Magliulo, D., Bernardi, R., & Messina, S. (2018). Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia. Frontiers in Oncology, 8, 255.
Pan, X., Cang, X., Dan, S., Li, J., Cheng, J., Kang, B., Duan, X., Shen, B., & Wang, Y. J. (2016). Site-specific Disruption of the Oct4/Sox2 Protein Interaction Reveals Coordinated Mesendodermal Differentiation and the Epithelial-Mesenchymal Transition. Journal of Biological Chemistry, 291(35), 18353–18369.
Duan, G., & Walther, D. (2015). The roles of post-translational modifications in the context of protein interaction networks. PLoS Computational Biology, 11(2), e1004049.
Deribe, Y. L., Pawson, T., & Dikic, I. (2010). Post-Translational Modifications in Signal Integration. Nature Structural & Molecular Biology, 17(6), 666–672.
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., et al. (2010). Regulation of cellular metabolism by protein lysine acetylation. Science, 327(5968), 1000–1004.
Consortium, U. (2010). The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Research, 38(suppl_1), D142–D148.
Brumbaugh, J., Hou, Z., Russell, J. D., Howden, S. E., Yu, P., Ledvina, A. R., Coon, J. J., & Thomson, J. A. (2012). Phosphorylation Regulates Human OCT4. Proceedings of the National Academy of Sciences, 109(19), 7162–7168.
Spelat, R., Ferro, F., & Curcio, F. (2012). Serine 111 Phosphorylation Regulates OCT4A Protein Subcellular Distribution and Degradation. Journal of Biological Chemistry, 287(45), 38279–38288.
Abulaiti, X., Zhang, H., Wang, A., Li, N., Li, Y., Wang, C., du, X., & Li, L. (2017). Phosphorylation of Threonine343 is Crucial for OCT4 Interaction with SOX2 in the Maintenance of Mouse Embryonic Stem Cell Pluripotency. Stem Cell Reports, 9(5), 1630–1641.
Bae, K. B., Yu, D. H., Lee, K. Y., Yao, K., Ryu, J., Lim, D. Y., Zykova, T. A., Kim, M. O., Bode, A. M., & Dong, Z. (2017). Serine 347 Phosphorylation by JNKs Negatively Regulates OCT4 Protein Stability in Mouse Embryonic Stem Cells. Stem Cell Reports, 9(6), 2050–2064.
Wu, Y., Guo, Z., Wu, H., Wang, X., Yang, L., Shi, X., et al. (2012). SUMOylation represses Nanog expression via modulating transcription factors Oct4 and Sox2. PLoS One, 7(6), e39606.
Kerscher, O., Felberbaum, R., & Hochstrasser, M. (2006). Modification of Proteins by Ubiquitin and Ubiquitin-Like Proteins. Annual Review of Cell and Developmental Biology, 22, 159–180.
Constable, S., Lim, J. M., Vaidyanathan, K., & Wells, L. (2017). O-GlcNAc Transferase Regulates Transcriptional Activity of Human Oct4. Glycobiology, 27(10), 927–937.
Cho, Y., Kang, H. G., Kim, S. J., Lee, S., Jee, S., Ahn, S. G., Kang, M. J., Song, J. S., Chung, J. Y., Yi, E. C., & Chun, K. H. (2018). Post-translational Modification of OCT4 in Breast Cancer Tumorigenesis. Cell Death and Differentiation, 25(10), 1781–1795.
Sharov, A. A., Masui, S., Sharova, L. V., Piao, Y., Aiba, K., Matoba, R., Xin, L., Niwa, H., & Ko, M. S. H. (2008). Identification of Pou5f1, Sox2, and Nanog Downstream Target Genes with Statistical Confidence by Applying a Novel Algorithm to Time Course Microarray and Genome-wide Chromatin Immunoprecipitation Data. BMC Genomics, 9(1), 269.
King, H. W., & Klose, R. J. (2017). The Pioneer Factor OCT4 Requires the Chromatin Remodeller BRG1 to Support Gene Regulatory Element Function in Mouse Embryonic Stem Cells. Elife, 6, e22631.
KRISHNAN, R. B., Jamry, I., & Chaplin, D. D. (1995). Feature Mapping of the HLA Class I Region: Localization of thePOU5F1andTCF19Genes. Genomics, 30(1), 53–58.
Guillaudeux, T., Mattel, M. G., Depetris, D., le Bouteiller, P., & Pontarotti, P. (1993). In situ Hybridization Localizes the Human OTF3 to Chromosome 6p21. 3→ p22 and OTF3L to 12p13. Cytogenetic and Genome Research, 63(4), 212–214.
Yang, W., Ng, P., Zhao, M., Wong, T. K. F., Yiu, S. M., & Lau, Y. (2008). Promoter-sharing by Different Genes in Human Genome–CPNE1 and RBM12 Gene Pair as an Example. BMC Genomics, 9(1), 456.
Yeom, Y. I., Fuhrmann, G., Ovitt, C. E., Brehm, A., Ohbo, K., Gross, M., Hübner, K., & Schöler, H. R. (1996). Germline Regulatory Element of Oct-4 Specific for the Totipotent Cycle of Embryonal Cells. Development, 122(3), 881–894.
Yoshimizu, T., Sugiyama, N., de Felice, M., Yeom, Y. I., Ohbo, K., Masuko, K., Obinata, M., Abe, K., Scholer, H. R., & Matsui, Y. (1999). Germline-Specific Expression of the Oct-4/green Fluorescent Protein (GFP) Transgene in Mice. Development, Growth & Differentiation, 41(6), 675–684.
Gillich, A., Bao, S., Grabole, N., Hayashi, K., Trotter, M. W. B., Pasque, V., Magnúsdóttir, E., & Surani, M. A. (2012). Epiblast Stem Cell-Based System Reveals Reprogramming Synergy of Germline Factors. Cell Stem Cell, 10(4), 425–439.
Okazawa, H., Okamoto, K., Ishino, F., Ishino-Kaneko, T., Takeda, S., Toyoda, Y., Muramatsu, M., & Hamada, H. (1991). The oct3 gene, a gene for an Embryonic Transcription Factor, is Controlled by a Retinoic Acid Repressible Enhancer. The EMBO Journal, 10(10), 2997–3005.
Minucci, S., Botquin, V., Yeom, Y. I., Dey, A., Sylvester, I., Zand, D. J., Ohbo, K., Ozato, K., & Scholer, H. R. (1996). Retinoic Acid-Mediated Down-Regulation of Oct3/4 Coincides with the loss of Promoter Occupancy in vivo. The EMBO Journal, 15(4), 888–899.
Yang, H. M., Do, H. J., Oh, J. H., Kim, J. H., Choi, S. Y., Cha, K. Y., Chung, H. M., & Kim, J. H. (2005). Characterization of Putative Cis-regulatory Elements that Control the Transcriptional Activity of the Human Oct4 Promoter. Journal of Cellular Biochemistry, 96(4), 821–830.
Hattori, N., Nishino, K., Ko, Y. G., Hattori, N., Ohgane, J., Tanaka, S., & Shiota, K. (2004). Epigenetic Control of Mouse Oct-4 Gene Expression in Embryonic Stem Cells and Trophoblast Stem Cells. Journal of Biological Chemistry, 279(17), 17063–17069.
Poursani, E. M., Mehravar, M., & Trosko, J. E. (2016). Microrna-1285 might potentially regulate OCT4 gene expression by direct targeting of its promoter. Journal of Evolving Stem Cell Research, 1(1), 10.
Janowski, B. A., Younger, S. T., Hardy, D. B., Ram, R., Huffman, K. E., & Corey, D. R. (2007). Activating Gene Expression in Mammalian Cells with Promoter-Targeted Duplex RNAs. Nature Chemical Biology, 3(3), 166–173.
Place, R. F., Li, L. C., Pookot, D., Noonan, E. J., & Dahiya, R. (2008). MicroRNA-373 Induces Expression of Genes with Complementary Promoter Sequences. Proceedings of the National Academy of Sciences, 105(5), 1608–1613.
Akpa, M. M., Iglesias, D. M., Chu, L. L., Cybulsky, M., Bravi, C., & Goodyer, P. R. (2015). Wilms Tumor Suppressor, WT1, Suppresses Epigenetic Silencing of the β-catenin gene. Journal of Biological Chemistry, 290(4), 2279–2288.
Wu, G., & Schöler, H. R. (2014). Role of Oct4 in the Early Embryo Development. Cell Regeneration, 3(1), 7.
Lander, E. S., et al. (2001). Erratum: Initial Sequencing and Analysis of the Human Genome: International Human Genome Sequencing Consortium (nature (2001) 409 (860-921)). Nature, 412(6846), 565–566.
Deininger, P. (2011). Alu Elements: Know the SINEs. Genome Biology, 12(12), 236.
Sorek, R., Ast, G., & Graur, D. (2002). Alu-containing Exons are Alternatively Spliced. Genome Research, 12(7), 1060–1067.
Chen, L.-L., & Yang, L. (2017). ALUternative Regulation for Gene Expression. Trends in Cell Biology, 27(7), 480–490.
Morales-Hernández, A., González-Rico, F. J., Román, A. C., Rico-Leo, E., Alvarez-Barrientos, A., Sánchez, L., Macia, Á., Heras, S. R., García-Pérez, J. L., Merino, J. M., & Fernández-Salguero, P. M. (2016). Alu Retrotransposons Promote Differentiation of Human Carcinoma Cells Through the Aryl Hydrocarbon Receptor. Nucleic Acids Research, 44(10), 4665–4683.
Makałowski, W., Mitchell, G. A., & Labuda, D. (1994). Alu Sequences in the Coding Regions of mRNA: A Source of Protein Variability. Trends in Genetics, 10(6), 188–193.
Sela, N., Mersch, B., Gal-Mark, N., Lev-Maor, G., Hotz-Wagenblatt, A., & Ast, G. (2007). Comparative Analysis of Transposed Element Insertion within Human and Mouse Genomes Reveals Alu's Unique Role in Shaping the Human Transcriptome. Genome Biology, 8(6), R127.
Athanasiadis, A., Rich, A., & Maas, S. (2004). Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biology, 2(12), e391.
Morse, D. P., Aruscavage, P. J., & Bass, B. L. (2002). RNA Hairpins in Noncoding Regions of Human Brain and Caenorhabditis Elegans mRNA are Edited by Adenosine Deaminases that act on RNA. Proceedings of the National Academy of Sciences, 99(12), 7906–7911.
Pain, D., Chirn, G. W., Strassel, C., & Kemp, D. M. (2005). Multiple Retropseudogenes from Pluripotent Cell-specific gene Expression Indicates a Potential Signature for Novel Gene Identification. Journal of Biological Chemistry, 280(8), 6265–6268.
Jez, M., Ambady, S., Kashpur, O., Grella, A., Malcuit, C., Vilner, L., et al. (2014). Expression and differentiation between OCT4A and its pseudogenes in human ESCs and differentiated adult somatic cells. PloS One, 9(2), e89546.
Scarola, M., et al. (2015). Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA. Nature Communications, 6(1), 1–13.
Zhao, S., Yuan, Q., Hao, H., Guo, Y., Liu, S., Zhang, Y., Wang, J., Liu, H., Wang, F., Liu, K., Ling, E. A., & Hao, A. (2011). Expression of OCT4 Pseudogenes in Human Tumours: Lessons from Glioma and Breast Carcinoma. The Journal of Pathology, 223(5), 672–682.
Suo, G., Han, J., Wang, X., Zhang, J., Zhao, Y., Zhao, Y., & Dai, J. (2005). Oct4 Pseudogenes are Transcribed in Cancers. Biochemical and Biophysical Research Communications, 337(4), 1047–1051.
Poursani, E. M., Soltani, B. M., & Mowla, S. J. (2016). Differential expression of OCT4 pseudogenes in pluripotent and tumor cell lines. Cell Journal (Yakhteh), 18(1), 28.
Wang, L., Guo, Z. Y., Zhang, R., Xin, B., Chen, R., Zhao, J., Wang, T., Wen, W. H., Jia, L. T., Yao, L. B., & Yang, A. G. (2013). Pseudogene OCT4-pg4 Functions as a Natural Micro RNA Sponge to Regulate OCT4 Expression by Competing for miR-145 in Hepatocellular Carcinoma. Carcinogenesis, 34(8), 1773–1781.
Bai, M., et al. (2015). OCT4 pseudogene 5 upregulates OCT4 expression to promote proliferation by competing with miR-145 in endometrial carcinoma. Oncology Reports, 33(4), 1745–1752.
Wu, G., & Schöler, H. R. (2014). Role of Oct4 in the Early Embryo Development. Cell Regeneration, 3(1), 1–10.
Ratajczak, M. Z., Ratajczak, J., & Kucia, M. (2019). Very Small Embryonic-Like Stem Cells (VSELs) an Update and Future Directions. Circulation Research, 124(2), 208–210.
Bhartiya, D., Anand, S., & Kaushik, A. (2020). Pluripotent very Small Embryonic-like Stem Cells Co-exist along with Spermatogonial Stem Cells in Adult Mammalian Testis. Human Reproduction Update, 26(1), 137–138.
Parte, S., Bhartiya, D., Telang, J., Daithankar, V., Salvi, V., Zaveri, K., & Hinduja, I. (2011). Detection, Characterization, and Spontaneous Differentiation in vitro of very Small Embryonic-like Putative Stem Cells in Adult Mammalian Ovary. Stem Cells and Development, 20(8), 1451–1464.
Patel, H., & Bhartiya, D. (2016). Testicular Stem Cells Express Follicle-Stimulating Hormone Receptors and are Directly Modulated by FSH. Reproductive Sciences, 23(11), 1493–1508.
Bhartiya, D. (2013). Are Mesenchymal Cells Indeed Pluripotent Stem Cells or just Stromal Cells? OCT-4 and VSELs Biology has Led to Better Understanding. Stem Cells International, 2013, 1–6.
Feldman, N., Gerson, A., Fang, J., Li, E., Zhang, Y., Shinkai, Y., Cedar, H., & Bergman, Y. (2006). G9a-Mediated Irreversible Epigenetic Inactivation of Oct-3/4 During Early Embryogenesis. Nature Cell Biology, 8(2), 188–194.
Author information
Authors and Affiliations
Contributions
M.M. and E.M.P. designed and wrote the manuscript. F.G. edited the manuscript.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mehravar, M., Ghaemimanesh, F. & Poursani, E.M. An Overview on the Complexity of OCT4: at the Level of DNA, RNA and Protein. Stem Cell Rev and Rep 17, 1121–1136 (2021). https://doi.org/10.1007/s12015-020-10098-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-020-10098-3